📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lanthiopharma

1.1 - Company Overview

Lanthiopharma Logo

Lanthiopharma

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug discovery focused on therapeutic lantipeptide drugs for serious diseases, applying proprietary lanthionine-peptide technology (LanthioPepTM) to generate novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lanthiopharma

Roivant Logo

Roivant

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines and healthcare technologies, developing VTAMA (tapinarof) cream for plaque psoriasis and atopic dermatitis in adults and children 2+, Brepocitinib (TYK2/JAK1) for dermatomyositis and non-infectious uveitis, IMVT-1402 (FcRn inhibitor) for autoimmune diseases including Graves' disease, Namilumab for sarcoidosis, and Mosliciguat for pulmonary hypertension associated with interstitial lung disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Roivant company profile →
Recordati Logo

Recordati

HQ: Italy Website
  • Description: Provider of medications and treatment options across specialty and primary care, consumer healthcare, and rare diseases, focusing on the development and distribution of therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Recordati company profile →
Antares Pharma Logo

Antares Pharma

HQ: United States Website
  • Description: Provider of specialty pharmaceutical products and drug-delivery technologies leveraging proprietary platforms, including ENHANZE® for subcutaneous delivery that can reduce hours-long IV infusions to minutes-long injections; subcutaneous and intramuscular auto-injectors; HYLENEX® recombinant to facilitate dispersion and absorption of injected drugs; XYOSTED® CIII testosterone enanthate injection; and a partner auto-injector pipeline used in five approved therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Antares Pharma company profile →
New Haven Pharmaceuticals Logo

New Haven Pharmaceuticals

HQ: United States Website
  • Description: Provider of prescription pharmaceuticals utilizing drugs or GRAS active pharmaceutical ingredients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full New Haven Pharmaceuticals company profile →
Pinteon Therapeutics Logo

Pinteon Therapeutics

HQ: United States Website
  • Description: Provider of a monoclonal antibody therapeutic, PNT001, targeting cis-pT231 tau to reduce neurodegeneration and cognitive impairment in traumatic brain injury, chronic traumatic encephalopathy, Alzheimer's disease, and progressive supranuclear palsy; advancing clinical studies of this novel antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pinteon Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lanthiopharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lanthiopharma

2.2 - Growth funds investing in similar companies to Lanthiopharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lanthiopharma

4.2 - Public trading comparable groups for Lanthiopharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lanthiopharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lanthiopharma

What does Lanthiopharma do?

Lanthiopharma is a provider of drug discovery focused on therapeutic lantipeptide drugs for serious diseases, applying proprietary lanthionine-peptide technology (LanthioPepTM) to generate novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity.

Who are Lanthiopharma's competitors?

Lanthiopharma's competitors and similar companies include Roivant, Recordati, Antares Pharma, New Haven Pharmaceuticals, and Pinteon Therapeutics.

Where is Lanthiopharma headquartered?

Lanthiopharma is headquartered in The Netherlands.

How many employees does Lanthiopharma have?

Lanthiopharma has 1,000 employees 🔒.

When was Lanthiopharma founded?

Lanthiopharma was founded in 2010 🔒.

What sector and industry vertical is Lanthiopharma in?

Lanthiopharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lanthiopharma

Who are the top strategic acquirers in Lanthiopharma's sector and industry

Top strategic M&A buyers and acquirers in Lanthiopharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lanthiopharma?

Top strategic M&A buyers groups and sectors for Lanthiopharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lanthiopharma's sector and industry vertical

Which are the top PE firms investing in Lanthiopharma's sector and industry vertical?

Top PE firms investing in Lanthiopharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lanthiopharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lanthiopharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lanthiopharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lanthiopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lanthiopharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lanthiopharma?

The key public trading comparables and valuation benchmarks for Lanthiopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lanthiopharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lanthiopharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lanthiopharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lanthiopharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lanthiopharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Lanthiopharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lanthiopharma